Literature DB >> 1464134

Wenckebach type heart block following spinal anaesthesia for caesarean section.

B F Matta1, P Magee.   

Abstract

A case is described of complete heart block during spinal anaesthesia for Caesarean section in a fit 23 yr-old-woman. This developed shortly after the institution of the block, with the height of the block below T5 and in the absence of hypotension. The patient was resuscitated successfully with vagolytic and alpha-agonist drugs. A Wenckebach block persisted for a short period postoperatively. The importance of instituting monitoring before the beginning of anaesthesia and the immediate availability of atropine and alpha-agonists before the initiation of spinal anaesthesia is stressed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464134     DOI: 10.1007/BF03008377

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  5 in total

1.  Bradycardia and asystole during spinal anesthesia: a report of three cases without morbidity.

Authors:  D C Mackey; R L Carpenter; G E Thompson; D L Brown; M N Bodily
Journal:  Anesthesiology       Date:  1989-05       Impact factor: 7.892

2.  Unexpected cardiac arrest during spinal anesthesia: a closed claims analysis of predisposing factors.

Authors:  R A Caplan; R J Ward; K Posner; F W Cheney
Journal:  Anesthesiology       Date:  1988-01       Impact factor: 7.892

3.  Cardiac arrests during spinal anesthesia: unexpected?

Authors:  R L Knill
Journal:  Anesthesiology       Date:  1988-10       Impact factor: 7.892

4.  Vasovagal asystole during spinal anaesthesia.

Authors:  I McConachie
Journal:  Anaesthesia       Date:  1991-04       Impact factor: 6.955

5.  Sick sinus syndrome manifest after spinal anaesthesia.

Authors:  S M Underwood; C J Glynn
Journal:  Anaesthesia       Date:  1988-04       Impact factor: 6.955

  5 in total
  1 in total

Review 1.  Spinal anaesthesia in obstetrics.

Authors:  P Morgan
Journal:  Can J Anaesth       Date:  1995-12       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.